Project Details
Description
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intranasal Midazolam (USL261) in the Outpatient Treatment of Subjects with Seizure Clusters
| Status | Finished |
|---|---|
| Effective start/end date | 4/5/11 → 12/31/20 |
Funding
- PHARMANET, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.